Angiogenesis inhibitors mainly targets VEGF and VEGFR, and reverses the immunosuppressive state of tumor microenvironment by blocking signal transduction pathways or reducing VEGF expression level of tumor cells. The gene discussed is KDR; the disease is neoplasm.